

Retatrutide 32 mg + Tesamorelin 32 mg
Pens bought separately IDR 6,900,000
Original documents
Open the original PDF published with this product. Check the report’s batch reference against the pack you are ordering.
Need a report for a particular batch? Ask our team on WhatsApp.
About the compound
Tesamorelin is an analogue of growth hormone-releasing hormone, or GHRH. Its research examines growth hormone signaling and changes in body composition.
The linked clinical trial studied abdominal fat accumulation in people living with HIV. That population and the visceral-fat outcome matter: the findings are not a general promise of weight loss for everyone.
These sources describe the compounds and study settings, rather than clinical testing of this finished Body Pharm pen.
For research and educational use only. Not for human or veterinary consumption. These products are research compounds and are not approved as medicines.